Task: Answer the multiple choice question.
Query: Which drug exhibits a -38.650% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) COc1ccc(NC(=S)N2CCCN(Cc3cccc(Cl)c3)C2)cc1
b) Cc1ccc2ncnc(-c3ccccc3)c2c1
c) Cc1ccc(NC(=O)CSc2nccc(=O)[nH]2)c(S(=O)(=O)N2CCOCC2)c1
Answer: a. COc1ccc(NC(=S)N2CCCN(Cc3cccc(Cl)c3)C2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=S)N2CCCN(Cc3cccc(Cl)c3)C2)cc1
COc1ccc(NC(=S)N2CCCN(Cc3cccc(Cl)c3)C2)cc1
3-[(3-chlorophenyl)methyl]-N-(4-methoxyphenyl)-1,3-diazinane-1-carbothioamide